Skip to content

Beta-alanine and Elder Endurance

The Interactive Effects Of Beta-Alanine Supplementation and Resistance Training on Muscular Endurance in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02821481
Enrollment
27
Registered
2016-07-01
Start date
2016-06-30
Completion date
2016-06-30
Last updated
2017-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Endurance

Keywords

Neuromuscular, Supplementation, Elderly

Brief summary

The purpose for this study is to determine if beta-alanine supplementation combined with endurance-based resistance training can increase gains in muscular endurance to a greater extent than endurance-based resistance-training alone in older adults.

Interventions

DIETARY_SUPPLEMENTBeta-alanine
DIETARY_SUPPLEMENTPlacebo
BEHAVIORALMuscular endurance exercise

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* 60-90 years of age * Living independently (not residing in an assisted living facility) * Through testing are found not to have sarcopenia * Gait speed \> 1 m/s * Skeletal Muscle Index \> 37% in men and \> 27.6 % in women *

Exclusion criteria

* Responding with a yes to any question on the PAR-Q. * Are currently pregnant, or plan to try and become pregnant during the study * Functional impairments that could impede the person's ability to participate in a resistance training program * Current or recent use of supplements (within the past 3 months for non-alanine containing supplements or one year for supplements containing beta-alanine). Individuals taking only basic multivitamins (without any herbal co-ingredients) may still be allowed to participate. These situations will be reviewed on a case-by-case basis. * Are currently enrolled in a regular exercise program (more than once per week) * Current or recent smoker * Use of medication containing corticosteroids * Mini-mental score of 21 or below * Severe musculoskeletal impairment * Uncontrolled chronic disease * Major depression * Severe vestibular problems

Design outcomes

Primary

MeasureTime frameDescription
Change in Performance of Daily Activitiesbaseline, 12 weeksShort Physical Functional Performance test

Secondary

MeasureTime frameDescription
Change in Body Fatbaseline, 12 weeksBody fat assessment via bioimpedance
Change in Muscular Endurancebaseline, 12 weeks20 repetitions to measure decline in muscular power across repetitions
Change in Muscular Strengthbaseline, 12 weeksMaximal weight that could be lifted one time (1RM)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026